References
Orange, J.S. et al. Nat. Immunol. https://doi.org/10.1038/s41590-018-0164-5 (2018).
Vély, F. et al. Nat. Immunol. 17, 1291–1299 (2016).
Dickinson, R. E. et al. Blood 118, 2656–2658 (2011).
Gineau, L. et al. J. Clin. Invest. 122, 821–832 (2012).
Cottineau, J. et al. J. Clin. Invest. 127, 1991–2006 (2017).
Hambleton, S. et al. N. Engl. J. Med. 365, 127–138 (2011).
Touzot, F. et al. Blood Adv. 1, 36–46 (2016).
Grier, J. T. et al. J. Clin. Invest. 122, 3769–3780 (2012).
Brown, M. G. et al. Science 292, 934–937 (2001).
Fischer, A. & Rausell, A. Sci. Immunol. 1, eaah5861 (2016).
Imai, K., Matsuyama, S., Miyake, S., Suga, K. & Nakachi, K. Lancet 356, 1795–1799 (2000).
Neven, B. et al. Blood 113, 4114–4124 (2009).
Gaspar, H. B., Harwood, C., Leigh, I. & Thrasher, A. J. Br. J. Haematol. 127, 232–233 (2004).
Laffort, C. et al. Lancet 363, 2051–2054 (2004).
Kamili, Q. U. A. et al. J. Allergy Clin. Immunol. 134, 1451–1453.e1 (2014).
Goldschmidt, M. H1. J. Virol. 80, 6621–6628 (2006).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
E.V. is an employee of Innate-Pharma.
Rights and permissions
About this article
Cite this article
Vivier, E., Vély, F. & Fischer, A. Reply to ‘Comment on: Evidence of innate lymphoid cell redundancy in humans’. Nat Immunol 19, 789–790 (2018). https://doi.org/10.1038/s41590-018-0165-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-018-0165-4
- Springer Nature America, Inc.